🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to see our founder and IIT Bombay Prof. Rahul Purwar (Rahul Purwar ) share the incredible journey of India’s first homegrown CAR-T cell therapy tomorrow at DBT-THSTI! #NationalTechnologyDay #MakeInIndia #CARTcell #ImmunoACT #NexCAR19

The latest in ImmunoACT’s interactive webinar series, held in association with the Deccan Hematology Group, will feature Dr. Sameer Melinkeri and Dr Kunal Goyal - leading experts in hematology and cellular therapy. Dr. Goyal will present an overview of NexCAR19, drawing on

At #CARTSummit2025, the session titled “Bridging the Gap - Role of NGOs and CSR in Providing Intent-to-Cure Solutions for Cancer Care” brought together experts from healthcare and the development sector to address access challenges in cancer treatment. Moderated by Ms. Sunita

Grateful to Technology Development Board and Dr. Rajesh Gokhale for highlighting India’s biotech progress. We're proud to contribute to the journey with our indigenous CAR-T cell therapy - making advanced cancer care more accessible and affordable. #NTD2025 #ImmunoACT #MakeInIndia #NexCAR19

At #CARTSummit2025, the panel discussion on “Treatment Selection, Sequencing, and Post-Infusion Management in the Optimal Use of CD19-CAR-T in B-NHLs” brought together leading clinicians to discuss critical decisions in CAR-T therapy for B-cell non-Hodgkin lymphomas. Chaired by

We are incredibly grateful to have been part of Professor Richard Watt’s journey from New Zealand to India for NexCAR19, our indigenous CAR-T cell therapy. His successful recovery after treatment at Cytecare Hospitals Hospitals is not just a medical milestone, but a powerful reminder of

Honoured to support the incredible team at DMCH in delivering Punjab’s first CAR-T cell therapy for a patient with relapsed leukemia and CNS involvement. Huge thanks to Dr. Suvir Singh (Suvir Singh) for leading the charge and sharing this milestone. From manufacturing to logistics

On 𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆, we are hosting a special webinar featuring two renowned experts in hematology. Dr. Rahul Bhargava, Fortis Hospital will speak on strategies to improve access to CAR-T cell therapy in India. This will be followed by Dr Kunal Goyal

𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 𝗦𝗲𝗿𝗶𝗲𝘀 | 𝗗𝗮𝘆 𝟭 – 𝗟𝗲𝘁’𝘀 𝗧𝗮𝗹𝗸 𝗔𝗯𝗼𝘂𝘁 𝗟𝘆𝗺𝗽𝗵𝗼𝗺𝗮 Behind every cancer statistic is a person, a family, a story. In India, over 𝟯𝟵,𝟬𝟬𝟬 people are diagnosed with lymphoma each year - and 𝟮𝟮,𝟬𝟬𝟬 don’t make

𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 𝗦𝗲𝗿𝗶𝗲𝘀 | 𝗗𝗮𝘆 𝟮 – 𝗟𝗲𝘁’𝘀 𝗧𝗮𝗹𝗸 𝗔𝗯𝗼𝘂𝘁 𝗟𝗲𝘂𝗸𝗲𝗺𝗶𝗮 Beyond the diagnosis is a childhood on pause, and a future worth fighting for. Yet, Acute Lymphoblastic Leukemia (ALL) accounts for 25% of all childhood cancers in

𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 𝗦𝗲𝗿𝗶𝗲𝘀 | 𝗗𝗮𝘆 𝟯 – 𝗔 𝗡𝗲𝘄 𝗘𝗿𝗮 𝗼𝗳 𝗛𝗼𝗽𝗲 Not all battles are visible - but every one of them deserves a powerful ally. For patients with blood cancers who’ve exhausted conventional treatments, there’s now a breakthrough

𝗪𝗲’𝗿𝗲 𝗟𝗶𝘃𝗲! 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗹𝗹-𝗡𝗲𝘄 𝗜𝗺𝗺𝘂𝗻𝗼𝗔𝗖𝗧 𝗪𝗲𝗯𝘀𝗶𝘁𝗲 Our new website is here - with a fresh design, smoother navigation, and everything you need to know about our CAR-T journey. Explore our product pipeline, learn more about #NexCAR19,

Our Founder, Prof. Rahul Purwar (Rahul Purwar), will be attending the 𝗘𝗛𝗔 𝟮𝟬𝟮𝟱 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀, a premier gathering in the field of hematology, taking place in Milan, Italy. 📅 June 12–15, 2025 📍 Milan, Italy Prof. Purwar will be present to connect with global

Join us for an insightful webinar featuring 𝗗𝗿. 𝗩𝗶𝗽𝘂𝗹 𝗦𝗵𝗲𝘁𝗵, a leading Hemato-oncologist in India, as he unpacks the "Escape Mechanism in CAR-T Cell Therapy". This session will delve into the scientific basis of escape pathways, clinical experiences, and their impact

We are honored to share the journey of Korak Abdulla Muhamad, the first patient from Yatharth Super Speciality Hospitals to receive #NexCAR19. In this inspiring testimonial, Korak reflects on his recovery from relapsed blood cancer through CAR-T cell therapy. Congratulations to

At ImmunoACT, our mission goes beyond engineering cutting-edge cell therapies - we are equally committed to creating meaningful impact within our community. This week, our team came together for a voluntary blood donation drive, standing united in the belief that there’s more